Literature DB >> 2532931

Inhibition of NAD glycohydrolase and ADP-ribosyl transferases by carbocyclic analogues of oxidized nicotinamide adenine dinucleotide.

J T Slama1, A M Simmons.   

Abstract

Analogues of oxidized nicotinamide adenine dinucleotide (NAD+) in which a 2,3-dihydroxycyclopentane ring replaces the beta-D-ribonucleotide ring of the nicotinamide riboside moiety of NAD+ have recently been synthesized [Slama, J. T., & Simmons, A. M. (1988) Biochemistry 27, 183]. Carbocyclic NAD+ analogues have been shown to inhibit NAD glycohydrolases and ADP-ribosyl transferases such as cholera toxin A subunit. In this study, the diastereomeric mixture of dinucleotides was separated, and the inhibitory capacity of each of the purified diastereomers was defined. The NAD+ analogue in which the D-dihydroxycyclopentane is substituted for the D-ribose is designated carba-NAD and was demonstrated to be a poor inhibitor of the Bungarus fasciatus venom NAD glycohydrolase. The diastereomeric dinucleotide pseudo-carbocyclic-NAD (psi-carba-NAD), containing L-dihydroxycyclopentane in place of the D-ribose of NAD+, was shown, however, to be a potent competitive inhibitor of the venom NAD glycohydrolase with an inhibitor dissociation constant (Ki) of 35 microM. This was surprising since psi-carba-NAD contains the carbocyclic analogue of the unnatural L-ribotide and was therefore expected to be a biologically inactive diastereomer. psi-Carba-NAD also competitively inhibited the insoluble brain NAD glycohydrolase from cow (Ki = 6.7 microM) and sheep (Ki = 31 microM) enzyme against which carba-NAD is ineffective. Sensitivity to psi-carba-NAD was found to parallel sensitivity to inhibition by isonicotinic acid hydrazide, another NADase inhibitor. psi-Carba-NAD is neither a substrate for nor an inhibitor of alcohol dehydrogenase, whereas carba-NAD is an efficient dehydrogenase substrate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532931     DOI: 10.1021/bi00445a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes.

Authors:  Brandi D Sanders; Kehao Zhao; James T Slama; Ronen Marmorstein
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

2.  Nicotinamide inhibits cyclic ADP-ribose-mediated calcium signalling in sea urchin eggs.

Authors:  J K Sethi; R M Empson; A Galione
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

3.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 4.  NAD hydrolysis: chemical and enzymatic mechanisms.

Authors:  N J Oppenheimer
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

5.  Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.

Authors:  Kehao Zhao; Robyn Harshaw; Xiaomei Chai; Ronen Marmorstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

6.  Synthesis of Stable NAD+ Mimics as Inhibitors for the Legionella pneumophila Phosphoribosyl Ubiquitylating Enzyme SdeC.

Authors:  Jerre M Madern; Robbert Q Kim; Mohit Misra; Ivan Dikic; Yong Zhang; Huib Ovaa; Jeroen D C Codée; Dmitri V Filippov; Gerbrand J van der Heden van Noort
Journal:  Chembiochem       Date:  2020-06-16       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.